Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-2-25
pubmed:databankReference
pubmed:abstractText
This study sought to report the long-term outcomes after drug-eluting stent (DES) implantation in saphenous vein graft (SVG) lesions in the SOS (Stenting of Saphenous Vein Grafts) trial.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1876-7605
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
176-82
pubmed:meshHeading
pubmed-meshheading:21349456-Aged, pubmed-meshheading:21349456-Angioplasty, Balloon, Coronary, pubmed-meshheading:21349456-Cardiovascular Agents, pubmed-meshheading:21349456-Coronary Angiography, pubmed-meshheading:21349456-Coronary Artery Bypass, pubmed-meshheading:21349456-Drug-Eluting Stents, pubmed-meshheading:21349456-Female, pubmed-meshheading:21349456-Graft Occlusion, Vascular, pubmed-meshheading:21349456-Humans, pubmed-meshheading:21349456-Kaplan-Meier Estimate, pubmed-meshheading:21349456-Male, pubmed-meshheading:21349456-Metals, pubmed-meshheading:21349456-Middle Aged, pubmed-meshheading:21349456-Myocardial Infarction, pubmed-meshheading:21349456-Paclitaxel, pubmed-meshheading:21349456-Proportional Hazards Models, pubmed-meshheading:21349456-Prosthesis Design, pubmed-meshheading:21349456-Risk Assessment, pubmed-meshheading:21349456-Risk Factors, pubmed-meshheading:21349456-Saphenous Vein, pubmed-meshheading:21349456-Single-Blind Method, pubmed-meshheading:21349456-Stents, pubmed-meshheading:21349456-Thrombosis, pubmed-meshheading:21349456-Time Factors, pubmed-meshheading:21349456-Treatment Outcome, pubmed-meshheading:21349456-United States
pubmed:year
2011
pubmed:articleTitle
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
pubmed:affiliation
Department of Cardiovascular Diseases, Veteran Affairs North Texas Healthcare System, Dallas, Texas, USA. esbrilakis@yahoo.com
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study